Çocuk Dergisi

GÖNDERBİLGİ
EnglishTürkçe

Derleme


DOI :10.5222/j.child.2014.138   IUP :10.5222/j.child.2014.138    Tam Metin (PDF)

Anneden Bebeğe HIV Geçişinin Önlenmesi

Murat Sütçü, Ayper Somer

Türkiye’de insan immün yetmezlik virüs (HIV) enfeksiyonu çok sık görülmemesine karşın, vaka sayısı giderek artmaktadır. Çocuklarda HIV enfeksiyonununda en önemli bulaş perinatal geçiş yoluyla olmaktadır. Anneden bebeğe perinatal geçişi, doğum öncesi, sırası ve sonrasında alınacak önlemler ile azaltmak mümkündür. Bu önlemler gebelik boyunca antiretroviral tedavi alma, doğumun 38. haftada sezaryen ile yapılması, bebeğe doğum sonrası antiretroviral profilaksi verilmesi ve anne sütü almama şeklinde özetlenebilir. Perinatal HIV enfeksiyonu bulaş oranı hiç tedavi almayan annelerde %12-40 iken standart perinatal profilaksi ile %3’ten, tam viral baskılanma sağlandığında da %1’den daha az oranlara iner. Bu derlemede, bir pediyatrik HIV merkezindeki anneden bebeğe perinatal geçişi önleme stratejilerinden bahsedildi.

Anahtar Kelimeler: HIV, perinatal geçiş, HIV ile temaslı bebek
DOI :10.5222/j.child.2014.138   IUP :10.5222/j.child.2014.138    Tam Metin (PDF)

Prevention of Mother to Child Transmisson of HIV Infection

Murat Sütçü, Ayper Somer

Despite the rare prevalence of Human İmmunedeficiency Virus (HIV) infection in Turkey, the number of new cases are rising, year by year. The most common route for transmission of HIV infection to children is by perinatal way; thus it can be prevented by special methods if applied properly during peripartum and postnatal periods. Antiretroviral therapy (ART) during pregnancy, birth by elective cesarian section at 38. weeks of gestational age, ART applied to baby just after birth and cessation of breastfeeding are the most important strategies for prevention of mother to child transmission (PMTCT) of HIV infection. The risk for perinatal HIV transmission is 12-40% in untreated mothers whereas this ratio drops to 3% by standart perinatal prophylaxis and less than 1% in the case when total viral supression is enabled. This review is the suggested summary of PMTCT strategies in a pediatric HIV clinic.

Anahtar Kelimeler: HIV, perinatal transmission, HIV exposed infant

PDF Görünüm

Referanslar

  • 1. World Health Organization. HIV/ AIDS. Accessible at: http://www.who.int/hiv/en/ google scholar
  • 2. World Health Organization. HIV/AIDS. Data and Statistics. Available at: http://www.who.int/hiv/data/en/ google scholar
  • 3. T.C. Sağlık Bakanlığı. HIV/AIDS verileri, Ekim 1985- Haziran 2014. Türkiye Halk Sağlığı Kurumu, Bulaşıcı Hastalıklar Daire Başkanlığı, Zührevi Hastalıklar Birimi. Erişim: http://www.hatam.hacettepe.edu.tr/ veriler_ Haziran_2014.pdf. google scholar
  • 4. World Health Organization, Unicef. Guidance on global scale-up of the prevention of mother to child transmission of HIV: towards universal access for women, infants and young children and eliminating HIV and AIDS among children / Inter-Agency Task Team on Prevention of HIV Infection in Pregnant Women, Mothers and their Children. WHO, 2007, Switzerland. Accessible at: http://www.unicef.org/aids/fi les/ PMTCT_enWEBNov26.pdf google scholar
  • 5. Mofenson L, Taylor AW, Rogers M, et al. Achievements in public health. Reduction in perinatal transmission of HIV infection- United States, 1985- 2005. MMWR Morb Mortal Wkly Rep 2006;55(21): 592-97. google scholar
  • 6. Townsend CL, Cortina-Borja M, Peckham CS, et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008;22(8): 973-81. http://dx.doi.org/10.1097/QAD.0b013e3282f9b67a google scholar
  • 7. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008;22(2):289-99. http://dx.doi.org/10.1097/QAD.0b013e3282f3d63c google scholar
  • 8. Read JS, Samuel NM, Srijayanth P, et al. Infants of human immunodefi ciency virus type 1-infected women in rural south India: feeding patterns and risk of mother-to-child transmission. Pediatr Infect Dis J 2010;29(1):14-7. http://dx.doi.org/10.1097/INF.0b013e3181b20ffc google scholar
  • 9. Hoffman RM, Black V, Technau K, et al. Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2010;54(1):35-41. http://dx.doi.org/10.1097/qai.0b013e3181cf9979 google scholar
  • 10. Koye DN, Zeleke BM. Mother-to-child transmission of HIV and its predictors among HIV-exposed infants at a PMTCT clinic in northwest Ethiopia. BMC Public Health 2013;13:398. http://dx.doi.org/10.1186/1471-2458-13-398 google scholar
  • 11. Del Bianco G, Bell CS, Benjamins LJ, et al. Persistently high perinatal transmission of HIV: assessment of risk factors. Pediatr Infect Dis J 2014;33(6): e151-7. http://dx.doi.org/10.1097/INF.0000000000000199 google scholar
  • 12. Pinnetti C, Baroncelli S, Villani P, et al. Rapid HIVRNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraeTablo 1. Antiretroviral profilakside kullanılan ilaçlar ve dozları. İlaç Zidovudin Nevirapin Lamuvidin Doz Term; 2 mg/kg/doz, 4 dozda oral, (1.5 mg/kg/doz iv) 30-35 GH; 2 mg/kg/doz, 2 dozda oral, (1.5 mg/kg/doz iv) 2 hafta sonra 3 doz < 30 GH; 2 mg/kg/doz, 2 dozda oral, (1.5 mg/kg/doz iv) 4 hafta sonra 3 doz 2 mg/kg/doz oral, tek doz, ilk 3 gün 2 mg/kg/doz oral, iki doz, ilk 1 hafta Çocuk Dergisi 14(4):138-142, 2014 142 mia at week 38 of pregnancy. J Antimicrob Chemother 2010;65(9):2050-52. http://dx.doi.org/10.1093/jac/dkq264 google scholar
  • 13. Coutsoudis A, Pillay K, Spooner E, et al. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS 1999;13(12):1517-24. http://dx.doi.org/10.1097/00002030-199908200-00012 google scholar
  • 14. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 1996;334(25):1617-23. http://dx.doi.org/10.1056/NEJM199606203342501 google scholar
  • 15. Mwanyumba F, Gaillard P, Inion I, et al. Placental inflammation and perinatal transmission of HIV-1. J Acquir Immune Defic Syndr 2002;29(3):262-9. http://dx.doi.org/10.1097/00042560-200203010-00006 google scholar
  • 16. World Health Organization, Centers for Disease Control and Prevention, Department of Health&Human Services. Prevention of Mother-to-Child Transmission of HIV (PMTCT). Generic Training Package. WHO 2004. Accessible at: www.cdc.gov/globalaids/ Resources/pmtct-care/docs/Complete_Presentation_ Bklt.pdf google scholar
  • 17. Menu E, Scarlatti G, Barré-Sinoussi F, et al. Motherto-child transmission of HIV: developing integration of healthcare programmes with clinical, social and basic research studies. Report of the International Workshop held at Chobe Marina Lodge, Kasane, Botswana, 21-25 January 2003. Acta Paediatr 2003;92(11):1343-8. http://dx.doi.org/10.1111/j.1651-2227.2003.tb00507.x google scholar
  • 18. Rousseau CM, Nduati RW, Richardson BA, et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 2003;187(5):741-7. http://dx.doi.org/10.1086/374273 google scholar
  • 19. UNAIDS, WHO, UNICEF. Joint WHO/UNAIDS/ UNICEF statement on use of cotrimoxazole as prophylaxis in HIV exposed and HIV infected children. 22 November 2004, Geneva. Accessible at: http://www. unaids.org/ google scholar
  • 20. Coutsoudis A, Kindra G, Esterhuizen T. Impact of cotrimoxazole prophylaxis on the health of breast-fed, HIV-exposed, HIV-negative infants in a resourcelimited setting. AIDS 2011; 25(14):1797-9. http://dx.doi.org/10.1097/QAD.0b013e32834ad699 google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Sütçü, M., & Somer, A. (2014). Anneden Bebeğe HIV Geçişinin Önlenmesi. Çocuk Dergisi, 14(4), 138-142. https://doi.org/10.5222/j.child.2014.138


AMA

Sütçü M, Somer A. Anneden Bebeğe HIV Geçişinin Önlenmesi. Çocuk Dergisi. 2014;14(4):138-142. https://doi.org/10.5222/j.child.2014.138


ABNT

Sütçü, M.; Somer, A. Anneden Bebeğe HIV Geçişinin Önlenmesi. Çocuk Dergisi, [Publisher Location], v. 14, n. 4, p. 138-142, 2014.


Chicago: Author-Date Style

Sütçü, Murat, and Ayper Somer. 2014. “Anneden Bebeğe HIV Geçişinin Önlenmesi.” Çocuk Dergisi 14, no. 4: 138-142. https://doi.org/10.5222/j.child.2014.138


Chicago: Humanities Style

Sütçü, Murat, and Ayper Somer. “Anneden Bebeğe HIV Geçişinin Önlenmesi.” Çocuk Dergisi 14, no. 4 (Jun. 2025): 138-142. https://doi.org/10.5222/j.child.2014.138


Harvard: Australian Style

Sütçü, M & Somer, A 2014, 'Anneden Bebeğe HIV Geçişinin Önlenmesi', Çocuk Dergisi, vol. 14, no. 4, pp. 138-142, viewed 5 Jun. 2025, https://doi.org/10.5222/j.child.2014.138


Harvard: Author-Date Style

Sütçü, M. and Somer, A. (2014) ‘Anneden Bebeğe HIV Geçişinin Önlenmesi’, Çocuk Dergisi, 14(4), pp. 138-142. https://doi.org/10.5222/j.child.2014.138 (5 Jun. 2025).


MLA

Sütçü, Murat, and Ayper Somer. “Anneden Bebeğe HIV Geçişinin Önlenmesi.” Çocuk Dergisi, vol. 14, no. 4, 2014, pp. 138-142. [Database Container], https://doi.org/10.5222/j.child.2014.138


Vancouver

Sütçü M, Somer A. Anneden Bebeğe HIV Geçişinin Önlenmesi. Çocuk Dergisi [Internet]. 5 Jun. 2025 [cited 5 Jun. 2025];14(4):138-142. Available from: https://doi.org/10.5222/j.child.2014.138 doi: 10.5222/j.child.2014.138


ISNAD

Sütçü, Murat - Somer, Ayper. “Anneden Bebeğe HIV Geçişinin Önlenmesi”. Çocuk Dergisi 14/4 (Jun. 2025): 138-142. https://doi.org/10.5222/j.child.2014.138



ZAMAN ÇİZELGESİ



LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ



İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.